Associate Director, Clinical Science

The Associate Director, Clinical Science serves as a key scientific contributor within the Clinical Development organization, partnering with Medical Directors to shape and execute the clinical and translational science strategy for BHB-1893 across the hypertrophic cardiomyopathy spectrum. This role plays a critical part in preparing the product for global Phase 3 execution and regulatory submissions by providing scientific leadership for protocol design, endpoint strategy, and clinical data review. The position involves translating complex datasets into clear scientific insights to inform program decisions and representing the science of BHB-1893 externally with key opinion leaders and the broader cardiovascular scientific community.